Skip to main content
SpringerLink
Log in

Focal Therapy in Other Genitourinary Systems: Renal Cell Carcinoma

  • Chapter
  • First Online:
Book cover Imaging and Focal Therapy of Early Prostate Cancer

Part of the book series: Current Clinical Urology ((CCU))

  • 1408 Accesses

Abstract

Over the last 2 years, an increase in axial imaging has led to corresponding increase in the incidence of small renal masses. Among the many treatment options available, cryoablation and radiofrequency ablation have established themselves as viable alternatives to surgical extirpation. In order to effectively ablate tumors, it is necessary to understand tumor biology, the technology being utilized, including limitations and outcome data, and the current guidelines. The purpose of this chapter is to describe these factors along with the surgical technique employed for tumor ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Luciana LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients. (1982–1997). Urology. 2000;56:58–62.

    Article  Google Scholar 

  2. Hollingsworth JM, Miller DC, Daignault S, et al. Rising Incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98: 1331–4.

    Article  PubMed  Google Scholar 

  3. Parsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology. 2001;57:1013–5.

    Article  PubMed  CAS  Google Scholar 

  4. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146:278.

    PubMed  CAS  Google Scholar 

  5. Huang HC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.

    Article  PubMed  Google Scholar 

  6. McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2006;59:819–20.

    Google Scholar 

  7. Bijol V, Mendez GP, Hurwitz S, et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30:575–84.

    Article  PubMed  Google Scholar 

  8. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179:468–73.

    Article  PubMed  Google Scholar 

  9. Novick AC, Campbell SC, Belldegrun A, et al. Guideline for management of the clinical stage 1 renal mass. American Urological Association. 2009. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm. Retrieved 28 Jul 2011

  10. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and review. J Urol. 2008;179:1227–34.

    Article  PubMed  Google Scholar 

  11. Rosales JC, Haramis G, Moreno J, et al. Active surveillance of renal cortical neoplasms. J Urol. 2010; 183:1698–702.

    Article  PubMed  Google Scholar 

  12. Graversen JA, Mues AC, Perez-Lanzac de Lorca A, et al. Active surveillance of renal cortical neoplasms: a contemporary review. J Post Grad Med. 2011; 123:105–13.

    Article  Google Scholar 

  13. Chawla AN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31.

    Article  PubMed  Google Scholar 

  14. Crispin PL, Viterbo R, Boorjian SA, et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844–52.

    Article  Google Scholar 

  15. Siu W, Hafez KS, Johnston WK, et al. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007;25:115–9.

    Article  PubMed  Google Scholar 

  16. Abou Youssif T, Kassouf W, Steinberg J, et al. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer. 2007;110:1010–4.

    Article  PubMed  Google Scholar 

  17. Taneja SS. The natural history of renal cortical neoplasms on active surveillance with longer than 5 year follow-up. J Urol. 2011;185:1639–40.

    Article  PubMed  Google Scholar 

  18. Remzi M, Özsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176:896–9.

    Article  PubMed  Google Scholar 

  19. Lane BR, Babineau D, Kattan MW, et al. A preoperative nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429–34.

    Article  PubMed  Google Scholar 

  20. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.

    Article  PubMed  Google Scholar 

  21. Lane BR, Aboussaly R, Gao T, et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer. 2010;116:3119–26.

    Article  PubMed  Google Scholar 

  22. Desai MM, Aron M, Gill IS. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology. 2005;66:23–8.

    Article  PubMed  Google Scholar 

  23. Lehman DS, Hruby GW, Phillips CK, et al. Laparoscopic renal cryoablation: efficacy and complications for larger renal masses. J Endourol. 2008;22:1123–8.

    Article  PubMed  Google Scholar 

  24. Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. Am J Roentgenol. 2007;188:1195–2000.

    Article  Google Scholar 

  25. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53.

    Article  PubMed  Google Scholar 

  26. Kutikov A, Uzzo RG. Fox Chase Center “R.E.N.A.L. score” R.E.N.A.L. nephrometry scoring system. http://www.nephrometry.com. Retrieved 6 Aug 2011

  27. Bruner B, Breau RH, Lohse CM, et al. Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int. 2011;108:67–72.

    Article  PubMed  Google Scholar 

  28. Hayn MH, Schwaab T, Underwood W, Kim HL. RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU Int. 2011;108(6):876–81.

    PubMed  Google Scholar 

  29. Gupta GN, Boris R, Chung P, et al. Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol. 2011 [epub ahead of Print].

    Google Scholar 

  30. White MA, Haber GP, Autorino R, Khanna R, Hernandez AV, Forest S, Yang B, Altunrende F, Stein RJ, Kaouk JH. Outcomes of robotic partial nephrectomy for renal masses with nephrometry score of ≥7. Urology. 2011;77:809–13.

    Article  PubMed  Google Scholar 

  31. Kutikov A, Smaldone MC, Egleston BL, et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL nephrometry score. Eur Urol. 2011;60:241–8.

    Article  PubMed  Google Scholar 

  32. Hew MN, Baseskioglu B, Barwari K, et al. Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol. 2011;86:42–6.

    Article  Google Scholar 

  33. Cha EK, Ng CK, Jeun B, et al. Pre-operative radiographic parameters predict long-term renal impairment following partial nephrectomy. World J Urol. 2011 May 21. [Epub ahead of Print].

    Google Scholar 

  34. Simhan J, Smaldone MC, Tsai KJ, et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol. 2011;60:724–30.

    Article  PubMed  Google Scholar 

  35. Reyes JM, Canter DJ, Sirohi M, et al. Delayed proximal ureteric stricture formation after complex partial nephrectomy. BJU Int. 2011;108:E232.

    Article  Google Scholar 

  36. Rosevear HM, Gellhouse PT, Lightfoot AJ, et al. Utility of RENAL nephrometry scoring system in the real world: predicting surgeon operative preferences and complication risk. BJU Int. 2012;109(5):700–5.

    Article  PubMed  Google Scholar 

  37. Kolla SB, Spiess PE, Sexton WJ. Interobserver reliability of the RENAL nephrometry scoring system. Urology. 2011;3(78):592–4.

    Article  Google Scholar 

  38. Simone G, Papalia R, Guaglianone S, et al. Zero ischemia laparoscopic partial nephrectomy after superselective transarterial tumor embolization for tumors with moderate nephrometry score: long-term results of a single-center experience. J Endourol. 2011;25: 1443–6.

    Article  PubMed  Google Scholar 

  39. Goel RK, Kaouk JH. Probe ablative treatment for small renal masses: cryoablation vs. radiofrequency ablation. Curr Opin Urol. 2008;18:467–73.

    Article  PubMed  Google Scholar 

  40. Rewcastle JC, Sandison GA, Saliken JC, et al. Considerations during clinical operation of two commercially available cryoablations. J Surg Oncol. 1999; 71:106–11.

    Article  PubMed  CAS  Google Scholar 

  41. Gill W, Fraser J, Carter DC. Repeated freeze-thaw cycles in cryosurgery. Nature. 1968;219:410–3.

    Article  PubMed  CAS  Google Scholar 

  42. Gill IS, Novick AC. Renal cryosurgery. Urology. 1999;54:215–9.

    Article  PubMed  CAS  Google Scholar 

  43. Campbell SC, Krishnamurthi V, Chow G, et al. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52:29–33.

    Article  PubMed  CAS  Google Scholar 

  44. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol. 1997;11:251–8.

    Article  PubMed  CAS  Google Scholar 

  45. Hsu TH, Fidler ME, Gill IS. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology. 2000;56:872–5.

    Article  PubMed  CAS  Google Scholar 

  46. Rehman J, Landman J, Lee D, et al. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J Endourol. 2004;18:83–104.

    Article  PubMed  Google Scholar 

  47. Young JL, Kolla SB, Pick DL, et al. In vitro, ex vivo and in vivo isotherms for renal cryotherapy. J Urol. 2010;183:752–8.

    Article  PubMed  Google Scholar 

  48. Aron M, Kamoi K, Remer E, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010;183:889–95.

    Article  PubMed  Google Scholar 

  49. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113:2671–80.

    Article  PubMed  Google Scholar 

  50. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176: 1973–7.

    Article  PubMed  Google Scholar 

  51. Ji C, Li X, Zhang S. Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. J Urol. 2011;77:798–802.

    Article  Google Scholar 

Download references

Acknowledgment

Figure photography by Jim Nicolais.

Author information

Authors and Affiliations

  1. Department of Urology, University of California, 333 City Boulevard West, Suite 2100, Irvine, CA, 92869, USA

    Joseph A. Graversen M.D.

  2. Department of Urology, University of California, 333 City Boulevard West, Suite 2100, Orange, CA, 92868, USA

    Jaime Landman M.D.

Authors
  1. Joseph A. Graversen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaime Landman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaime Landman M.D. .

Editor information

Editors and Affiliations

  1. , Department of Surgery, Duke Cancer Institute, Room 1089 Duke South, Durham, 27710, North Carolina, USA

    Thomas J. Polascik

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Graversen, J.A., Landman, J. (2013). Focal Therapy in Other Genitourinary Systems: Renal Cell Carcinoma. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-182-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-182-0_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-181-3

  • Online ISBN: 978-1-62703-182-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation